GlassScriptPhysician profile
Theodore J Steelman
NPI 1184979684
$6,606.67
in general payments reported to CMS, 2019-2025
9 companies · $1,593 in 2025
The $1,593 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $167 · 2021: $206 · 2022: $1,591 · 2023: $1,974 · 2024: $1,075 · 2025: $1,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,956 · Food and Beverage: $1,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,955.61 |
| Food and Beverage | $1,686.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $1,571.68 | 2025 | Prodisc L |
| Stryker Corporation | $1,543.55 | 2020-2023 | Yukon Oct Spinal System, Everest Spinal System |
| Nuvasive, INC. | $1,331.44 | 2022-2023 | Xlif, Tlx, Reline |
| Globus Medical, INC. | $1,095.89 | 2023-2024 | Xlif, Excelsiusgps Robotic Navigation System |
| Kuros Biosciences USA, INC | $538.89 | 2023 | |
| Alphatec Spine, INC | $300.80 | 2021-2023 | Solus Alif |
| Depuy Synthes Sales INC. | $161.75 | 2023-2025 | Sentio, Expedium, Teligen |
| Pacira Therapeutics, INC. | $50.92 | 2021 | |
| Conformis, INC. | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Steelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.